- 期刊
2017年KDIGO慢性腎病礦物質和骨骼疾病（CKD-MBD）指引更新摘要
Summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder Guideline Update
摘要
2009年Kidney Disease: Improving Global Outcomes（KDIGO）發布了第一版的慢性腎病礦物質和骨骼疾病（chronic kidney disease-minerals and bone diseases, CKD-MBD）臨床指引用於診斷、評估、預防和治療。隨後幾年，隨著多個隨機對照試驗和前瞻性研究相繼發表，KDIGO重新檢視後於2017年發布對CKD-MBD臨床指引之更新，對CKD-MBD提出新的臨床建議。本文將介紹指引更新的主要部分及更改的依據，雖然醫療制度及給付條件不同，臨床上不可能完全照著指引來機械化地照顧病患，但指引內容對於醫療人員的病人照護，仍可予以相當大的啟發。
並列摘要
In 2009, Kidney Disease Improving Global Outcomes (KDIGO) released the first edition of the clinical guidelines for chronic kidney disease-minerals and bone diseases (CKD-MBD) for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. However, with the many multiple randomized controlled trials and prospective cohort studies published in following years, KDIGO re-examined its guidelines and released the 2017 KDIGO CKD-MBD Guideline Update to provide clinical recommendations for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. We will introduce the major renewed provisions and the evidences for their change in the 2017 CKD-MBD Guidelines Update. Although the medical system and payment conditions are different, it is clinically impossible to meticulously take care of the patients according to the guidelines. However, the guidelines can still give considerable inspiration to the medical care of medical personnel.